Coagulation-related genes for thyroid cancer prognosis, immune infltration, staging, and drug sensitivity
View abstract on PubMed
Summary
This summary is machine-generated.Coagulation biomarker D-dimer predicts lateral lymph node metastasis in thyroid cancer (THCA). A prognostic model based on 8 coagulation-related genes improves risk stratification for personalized THCA therapy.
Area Of Science
- Endocrinology
- Oncology
- Molecular Biology
- Biomarker Discovery
Background
- Thyroid cancer (THCA) is the most common endocrine malignancy.
- The role of coagulation in THCA development and progression remains unclear.
- Identifying predictive biomarkers for THCA metastasis is crucial for patient management.
Purpose Of The Study
- To evaluate the predictive value of D-dimer for lateral lymph node metastasis (LLNM) in THCA patients.
- To identify coagulation-related genes (CRGs) associated with THCA prognosis.
- To construct and validate a prognostic model for THCA based on CRGs.
Main Methods
- Receiver operating characteristic (ROC) and logistic regression analyses were used to assess D-dimer's predictive value for LLNM.
- Consensus clustering analysis of TCGA database identified coagulation-related molecular subtypes.
- LASSO regression selected 8 CRGs to build a prognostic model, followed by risk stratification, nomogram construction, and RT-qPCR validation.
Main Results
- D-dimer demonstrated predictive value for LLNM (AUC=0.656), with elevated levels (>0.065 mg/l) being an independent predictor.
- A prognostic model using 8 CRGs effectively distinguished between high-risk and low-risk THCA patients (P<0.001).
- Significant differences in clinical characteristics, gene mutations, immune infiltration, and drug sensitivity were observed between risk groups; 8 CRGs were overexpressed in THCA cell lines.
Conclusions
- Coagulation biomarkers, particularly D-dimer, hold significant potential for predicting LLNM in THCA.
- The developed prognostic model based on CRGs offers a novel tool for risk stratification and personalized therapy in THCA.
- This study provides a foundation for understanding coagulation's role in THCA and guides future research in targeted treatments.
Related Concept Videos
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

